These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35535402)

  • 1. Averting neonatal abstinence syndrome and treating addiction among rural, opioid-using young women.
    Cooper RL; Crosby RA; Martin PR; Edgerton R
    Am J Addict; 2022 Sep; 31(5):441-446. PubMed ID: 35535402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
    Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
    Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.
    Rinehart DJ; Stowell M; Collings A; Durfee MJ; Thomas-Gale T; Jones HE; Binswanger I
    J Subst Abuse Treat; 2021 Jul; 126():108318. PubMed ID: 34116817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
    Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
    Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.
    Jones HE; Martin CE; Andringa KR; Ellerson RM; Johnson E; Hairston E; O' Grady KE
    Drug Alcohol Depend; 2021 Apr; 221():108634. PubMed ID: 33676071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
    Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
    Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.
    Goyal S; Monsour M; Ko JY; Curtis KM; Whiteman MK; Coy KC; Cox S; Romero L
    Contraception; 2023 Jan; 117():67-72. PubMed ID: 36243128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications for opioid use disorder in pregnancy in a state women's prison facility.
    Knittel AK; Zarnick S; Thorp JM; Amos E; Jones HE
    Drug Alcohol Depend; 2020 Sep; 214():108159. PubMed ID: 32683223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.
    Stancil SL; Miller MK; Duello A; Finocchario-Kessler S; Goggin K; Winograd RP; Hurley EA
    Harm Reduct J; 2021 Aug; 18(1):83. PubMed ID: 34348734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum and addiction recovery of women in opioid use disorder treatment: A qualitative study.
    Martin CE; Almeida T; Thakkar B; Kimbrough T
    Subst Abus; 2022; 43(1):389-396. PubMed ID: 34214405
    [No Abstract]   [Full Text] [Related]  

  • 12. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
    Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
    Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy.
    Mason I; Mashburn S; Cleary E; Abdelwahab M; Ma'ayeh M; Rood KM
    J Addict Med; 2022 Jul-Aug 01; 16(4):420-424. PubMed ID: 35960213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
    Paterno MT; Jablonski L; Klepacki A; Friedmann PD
    J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.
    Wachman EM; Saia K; Miller M; Valle E; Shrestha H; Carter G; Werler M; Jones H
    Clin Ther; 2019 Sep; 41(9):1681-1689. PubMed ID: 31358302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.
    ;
    Obstet Gynecol; 2012 May; 119(5):1070-6. PubMed ID: 22525931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
    Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
    J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.